Connect to other sites within the UBM Medica Network
The risk includes a 1.99X higher risk for stroke and 1.93X higher risk of CV mortality.
New Analyses Only Partly Defuse ROCKET-AF Trial Concerns
Critics continue to call for independent analysis by outside investigators not involved with the original trial.
Women with Atrial Fibrillation at Higher Cardiovascular Risk vs Men
The risk includes a 1.99X higher risk for stroke and 1.93X higher risk of CV mortality, according to new research.
Exercise with Atrial Fibrillation? Yes, in Moderation
Results of a Norwegian study add to the evidence that shows moderate aerobic exercise is appropriate in patients with symptomatic AF.
7 Modifiable Risk Factors for Atrial Fibrillation
Find data here on obesity, exercise, and OSA, plus 4 more factors that increase the risk for AF and other CV disease.
Risk of Atrial Fibrillation is Associated with Gout
A large population-based study found more patients already had atrial fibrillation at gout diagnosis compared with controls.
ROCKET-AF Trial Results Under Fire
Concern that equipment error may have led to higher doses of warfarin than necessary call the huge trial's findings into question.
To Bridge or Not To Bridge? Is it the Wrong Question?
Results of two recent studies suggest that perioperative "bridge" anticoagulation may do more harm than good in some patients.
Atrial Fibrillation Video: Symptoms, Cardioversion Strategies
A nurse describes his own bout with atrial fibrillation—the symptoms and his attempts to cardiovert to normal rhythm—from his hospital bed.
Secondary AF: Risk of Recurrence Found in Framingham
Is new-onset AF linked to an acute precipitant less likely to recur than spontaneous AF? Is it any less dangerous? A new study finds answers in Framingham data.
Obesity and AF: A Dose-dependent Relationship
A recent literature analysis found a 10% to 29% excess risk for AF conferred by incremental increases in BMI. The study in 9 slides, here.
3 Myths About New Oral Anticoagulants Debunked for Primary Care Physicians
No monitoring necessary; don't use them before electrical cardioversion; and count them out for periprocedural use during AF ablation. Really?
Just Say No to Anticoagulation for These Patients With Atrial Fibrillation
Guidelines say “no” to anticoagulation for young, otherwise healthy persons with atrial fibrillation. New research finds that clinical practice looks quite different.
By clicking Accept, you agree to become a member of the UBM Medica Community.